| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 10/02/2007 | US7276236 Methods of preparing immune globin and uses thereof |
| 10/02/2007 | CA2419046C Method for detecting or measuring hbv |
| 10/02/2007 | CA1341552C Method of producing human-human hybridomas, the production of monoclonal and polyclonal antibodies therefrom, and therapeutic use thereof |
| 09/27/2007 | WO2007109686A2 Immunomodulation of inflammatory conditions utilizing follistatin-like protein-1 and agents that bind thereto |
| 09/27/2007 | WO2007109567A1 Anti-tat226 antibodies and immunoconjugates |
| 09/27/2007 | WO2007108756A1 Improved protofibril selective antibodies and the use thereof |
| 09/27/2007 | WO2007108559A1 Agonistic antibody directed against human thrombopoietin receptor |
| 09/27/2007 | WO2007108557A1 Control of intracellular target molecule by ip3 receptor-binding protein |
| 09/27/2007 | WO2007108464A1 Antibody directed against mammal-derived cytoplasmic sialidase |
| 09/27/2007 | WO2007108368A1 Panel cell used for granulocyte antibody detection |
| 09/27/2007 | WO2007108152A1 High functional bispecific antibody |
| 09/27/2007 | WO2007107797A2 Fusion protein comprising an fc receptor binding polypeptide and an antigenic polypeptide for mediating an immune response |
| 09/27/2007 | WO2007107764A1 Reversibly inhibited antibodies for immune cell stimulation |
| 09/27/2007 | WO2007107759A1 Peptide derived from colostrum |
| 09/27/2007 | WO2007107349A1 Antibody specific for human il-4 for the treament of cancer |
| 09/27/2007 | WO2007107329A1 Tumor therapy with an antibody for vascular endothelial groeth factor and an antibody for human epithelial growth factor receptor type 2 |
| 09/27/2007 | WO2007081790A3 Methods for diagnosing and treating prostate cancer |
| 09/27/2007 | WO2007050531A3 Diagnostic application of mail |
| 09/27/2007 | WO2006017318A3 Methods for treating cancer using agents that inhibit wnt16 signaling |
| 09/27/2007 | WO2005046583A3 Modified fviii having reduced immunogenicity through mutagenesis of a2 and c2 epitopes |
| 09/27/2007 | US20070225480 small ubiquitin-like modifier (SUMO); for diagnosis and treatment of Type 1 diabetes |
| 09/27/2007 | US20070225240 Screening Assay and Treatment |
| 09/27/2007 | US20070225222 Use of heparin-binding domain of fibronectin for diagnosis and treatment of cancer |
| 09/27/2007 | US20070225221 Methods of treatment using specific binding agents of human angiopoietin-2 |
| 09/27/2007 | US20070225218 Extracellular Messengers |
| 09/27/2007 | US20070225202 Methods for Identifying Modulators of Active Kit Tyrosine Kinase Receptor |
| 09/27/2007 | US20070224664 System for Antibody Expression and Assembly |
| 09/27/2007 | US20070224649 Novel scavenger receptor |
| 09/27/2007 | US20070224634 Methods for Detecting L-Ficolin Dependent Activation of the Lectin Pathway of Complement and Kits Therefor |
| 09/27/2007 | US20070224211 HIV-1 glycopeptides and derivatives; preparation and applications thereof |
| 09/27/2007 | US20070224204 Combination therapy of respiratory diseases using antibodies and anti-inflammatory agents |
| 09/27/2007 | US20070224202 contains the idiotype of the HE2 antibody directed against the cellular membrane antigen Ep-CAM |
| 09/27/2007 | US20070224201 Maytansinoid conjugated immunoglobulin for use in prevention, detection and treatment of cell proliferative disorders |
| 09/27/2007 | US20070224199 Targeting of MKRN1 for Identifying Cancer Treatment Agents |
| 09/27/2007 | US20070224198 Antithrombotic agents |
| 09/27/2007 | US20070224197 Three-dimensional structure of complement receptor type 2 and uses thereof |
| 09/27/2007 | US20070224196 Immunogenicity-reduced anti-cr1 antibody and compositions and methods of treatment based thereon |
| 09/27/2007 | US20070224192 antibody or immunoadhesin increases binding affinity to an Fc variants; amino acid substitution; glycosylated Fc; computer aided drug design; drug target |
| 09/27/2007 | US20070224191 Methods of treatment of Ulcerative Colitis and Crohn's disease with anti-CD3 antibodies |
| 09/27/2007 | US20070224190 Anti-amyloid immunogenic compositions, methods and uses |
| 09/27/2007 | US20070224189 CD20 OPTIMIZED Fc VARIANTS AND METHODS FOR THEIR GENERATION |
| 09/27/2007 | US20070224188 humanized anti-CD20 antibodies comprising a human IgG1 Fc region; for treating lymphoma |
| 09/27/2007 | US20070224187 Method of treating a pathological syndrome and a pharmaceutical agent |
| 09/27/2007 | US20070224186 Diagnostic methods for diseases by screening for hepcidin in human or animal tissues, blood or body fluids; monoclonal antibodies specific to human hepcidin and associated uses therefor |
| 09/27/2007 | US20070224185 Secreted and Transmembrane Polypeptides and Nucleic Acids Encoding the Same |
| 09/27/2007 | US20070224178 Multimeric constructs |
| 09/27/2007 | US20070224166 Uses of mammalian cytokine; related reagents |
| 09/27/2007 | US20070224125 Polypeptide of given sequence; transforming or transfecting cell with expression vector; inhibits tumor necrosis factor release; anti-inflammatory |
| 09/27/2007 | US20070224121 Connective Tissue Growth Factor-4 |
| 09/27/2007 | CA2647769A1 Control of intracellular target molecule by ip3 receptor-binding protein |
| 09/27/2007 | CA2647380A1 Methods for humanizing antibodies and humanized antibodies made thereby |
| 09/27/2007 | CA2647107A1 Anti-tumor cell antigen antibody therapeutics |
| 09/27/2007 | CA2646934A1 Methods for reducing protein aggregation |
| 09/27/2007 | CA2646643A1 Methods for preventing and treating amyloidogenic diseases |
| 09/27/2007 | CA2646626A1 Antibody specific for human il-4 for the treatment of cancer |
| 09/27/2007 | CA2646508A1 Stabilized polypeptide compositions |
| 09/27/2007 | CA2646329A1 Engineered anti-prostate stem cell antigen (psca) antibodies for cancer targeting |
| 09/27/2007 | CA2645891A1 Tumor therapy with an antibody for vascular endothelial groeth factor and an antibody for human epithelial growth factor receptor type 2 |
| 09/27/2007 | CA2645831A1 Anti-tat226 antibodies and immunoconjugates |
| 09/27/2007 | CA2645322A1 Methods of treating lupus using cd4 antibodies |
| 09/27/2007 | CA2644663A1 Agonist antibody to human thrombopoietin receptor |
| 09/27/2007 | CA2638755A1 Methods and compositions for antagonism of rage |
| 09/27/2007 | CA2630344A1 Improved protofibril selective antibodies and the use thereof |
| 09/26/2007 | EP1837400A1 Novel tannase gene and protein thereof |
| 09/26/2007 | EP1837396A1 Salutaridine reductase and morphine biosynthesis |
| 09/26/2007 | EP1837342A2 Sodium-channel alpha 1-subunit and their polypeptides and their treatment of generalised epilepsy with febrile seizures plus |
| 09/26/2007 | EP1836317A2 Methods and compositions for detecting bacillus anthracis |
| 09/26/2007 | EP1836315A2 Zebrafish heterotrimer g-protein gamma 2 subunit (gng2) |
| 09/26/2007 | EP1836294A2 Anti-il-12 antibodies, epitopes, compositions, methods and uses |
| 09/26/2007 | EP1836226A1 Antibodies against il-13 receptor alpha 1 and uses thereof |
| 09/26/2007 | EP1836225A1 Kir-binding agents and methods of use thereof |
| 09/26/2007 | EP1836224A1 Bcma polypeptides and uses thereof |
| 09/26/2007 | EP1835937A2 Compositions and methods for treating viral infection |
| 09/26/2007 | EP1835935A2 Compositions and methods for enhanced dendritic cell maturation and function |
| 09/26/2007 | EP1835929A2 Anti-kir combination treatments and methods |
| 09/26/2007 | EP1835926A2 Plasmin-inhibitory therapies |
| 09/26/2007 | EP1835922A1 Combination treatment for multiple sclerosis |
| 09/26/2007 | EP1495142B1 "doping" in walk-through mutagenesis |
| 09/26/2007 | EP1391464B1 Anti-cd40 monoclonal antibody |
| 09/26/2007 | EP1346054B1 Nucleic acids coding for vacuolar invertases, vegetal cells and plants containing said nucleic acids and the use thereof |
| 09/26/2007 | EP1194447B1 Novel potassium channels and genes encoding these potassium channels |
| 09/26/2007 | EP0937140B1 Antibody molecules which interact specifically with the active site or cleft of a target molecule |
| 09/26/2007 | EP0787191B1 Nucleotide sequences of hiv-1 type (or subtype) o retrovirus antigens |
| 09/26/2007 | CN101044247A Compositions, kits, and methods for identification, assessment, prevention, and therapy of cervical cancer |
| 09/26/2007 | CN101044242A Tumor specific antibody |
| 09/26/2007 | CN101044165A Irta-4 antibodies and their uses |
| 09/26/2007 | CN101044164A Inhibitors of angiopoietin-like 4 protein, combinations, and their use |
| 09/26/2007 | CN101044163A Immunoglobulins comprising predominantly a glcnac2man3glcnac2 glycoform |
| 09/26/2007 | CN101044160A Methods of diagnosis and treatment of m. tuberculosis infection and reagents therefor |
| 09/26/2007 | CN101043947A Method of antibody purification |
| 09/26/2007 | CN101041820A Macrophagocyte transfer inhibition factor monoclonal antibody and method for making same |
| 09/26/2007 | CN101041817A Hybridomas, monoclonal antibody and method for making same and usage thereof |
| 09/26/2007 | CN101041697A Anti-protein expression label antibody or antibody compound and preparation method and application thereof |
| 09/26/2007 | CN101041696A Preparation method of heavy metallic lead resistant monoclonal antibody |
| 09/26/2007 | CN101041695A 番茄环斑病毒单克隆抗体 Tomato ringspot virus monoclonal antibody |
| 09/26/2007 | CN101041694A Angiogenin-like protein V and preparation method thereof, its polyclonal antibody and uses thereof |
| 09/26/2007 | CN100339395C E type hepatitis virus monoclonal antibody or its conjugated active fragment and use thereof |
| 09/26/2007 | CN100339386C Animal composite immune globulin production method |
| 09/26/2007 | CN100339132C Antithrombotic agents |
| 09/25/2007 | US7273964 Non-human transgenic animals for the study of neurodegenerative syndromes |